StockWatch
·
Healthcare Service Provider
Quarterly Result21 Jan 2026, 04:02 pm

Gian Life Care Ltd Schedules Board Meeting to Approve Q3 Results for FY2025-26

AI Summary

Gian Life Care Ltd has informed the BSE that its Board of Directors will meet on January 24, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended September 30, 2025. The meeting, originally scheduled for February 21, 2026, has been rescheduled. The trading window for dealing in shares of the company has been closed for Directors, KMP’s, Designated Employees and Connected Persons from October 1, 2025, and will remain closed till 48 hours after the information is made public.

Key Highlights

  • Gian Life Care Ltd to consider and approve Q3 FY2025-26 results on January 24, 2026
  • Meeting rescheduled from February 21, 2026
  • Trading window for shares closed from October 1, 2025, for Directors, KMP’s, Designated Employees and Connected Persons